OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative m... von Robson, M.E., Tung, N., Conte, P., Im, S.-A., Senkus, E., Xu, B., Masuda, N., Delaloge, S., Li, W., Armstrong, A., Wu, W., Goessl, C., Runswick, S., Domchek, S.M.

Volltext

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer von Gennari, A., André, F., Barrios, C.H., Cortés, J., de Azambuja, E., DeMichele, A., Dent, R., Fenlon, D., Gligorov, J., Hurvitz, S.A., Im, S.-A., Krug, D., Kunz, W.G., Loi, S., Penault-Llorca, F., Ricke, J., Robson, M., Rugo, H.S., Saura, C., Schmid, P., Singer, C.F., Spanic, T., Tolaney, S.M., Turner, N.C., Curigliano, G., Loibl, S., Paluch-Shimon, S., Harbeck, N.

Volltext

Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 stud... von Schmid, P., Salgado, R., Park, Y.H., Muñoz-Couselo, E., Kim, S.B., Sohn, J., Im, S.-A., Foukakis, T., Kuemmel, S., Dent, R., Yin, L., Wang, A., Tryfonidis, K., Karantza, V., Cortés, J., Loi, S.

Volltext

Core/Shell Nanoparticles as Electrocatalysts for Fuel Cell Reactions von Luo, Jin, Wang, Lingyan, Mott, Derrick, Njoki, Peter N., Lin, Yan, He, Ting, Xu, Zhichuan, Wanjana, Bridgid N., Lim, I.-Im S., Zhong, Chuan-Jian

Volltext

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases von Turner, N.C., Finn, R.S., Martin, M., Im, S.-A., DeMichele, A., Ettl, J., Diéras, V., Moulder, S., Lipatov, O., Colleoni, M., Cristofanilli, M., Lu, D.R., Mori, A., Giorgetti, C., Iyer, S., Bartlett, C. Huang, Gelmon, K.A.

Volltext

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy von Masuda, Norikazu, Lee, Soo-Jung, Ohtani, Shoichiro, Im, Young-Hyuck, Lee, Eun-Sook, Yokota, Isao, Kuroi, Katsumasa, Im, Seock-Ah, Park, Byeong-Woo, Kim, Sung-Bae, Yanagita, Yasuhiro, Ohno, Shinji, Takao, Shintaro, Aogi, Kenjiro, Iwata, Hiroji, Jeong, Joon, Kim, Aeree, Park, Kyong-Hwa, Sasano, Hironobu, Ohashi, Yasuo, Toi, Masakazu

Volltext

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant von Neven, P, Fasching, P A, Chia, S, Jerusalem, G, De Laurentiis, M, Im, S-A, Petrakova, K, Bianchi, G V, Martín, M, Nusch, A, Sonke, G S, De la Cruz-Merino, L, Beck, J T, Zarate, J P, Wang, Y, Chakravartty, A, Wang, C, Slamon, D J

Volltext

Climate hazard indices projections based on CORDEX-CORE, CMIP5 and CMIP6 ensemble von Coppola, Erika, Raffaele, Francesca, Giorgi, Filippo, Giuliani, Graziano, Xuejie, Gao, Ciarlo, James M., Sines, Taleena Rae, Torres-Alavez, José Abraham, Das, Sushant, di Sante, Fabio, Pichelli, Emanuela, Glazer, Russell, Müller, Sebastian Karl, Abba Omar, Sabina, Ashfaq, Moetasim, Bukovsky, Melissa, Im, E.-S., Jacob, Daniela, Teichmann, Claas, Remedio, Armelle, Remke, Thomas, Kriegsmann, Arne, Bülow, Katharina, Weber, Torsten, Buntemeyer, Lars, Sieck, Kevin, Rechid, Diana

Volltext

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer von Modi, Shanu, Saura, Cristina, Yamashita, Toshinari, Park, Yeon Hee, Kim, Sung-Bae, Tamura, Kenji, Andre, Fabrice, Iwata, Hiroji, Ito, Yoshinori, Tsurutani, Junji, Sohn, Joohyuk, Denduluri, Neelima, Perrin, Christophe, Aogi, Kenjiro, Tokunaga, Eriko, Im, Seock-Ah, Lee, Keun Seok, Hurvitz, Sara A, Cortes, Javier, Lee, Caleb, Chen, Shuquan, Zhang, Lin, Shahidi, Javad, Yver, Antoine, Krop, Ian

Volltext

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer von Schmid, Peter, Adams, Sylvia, Rugo, Hope S, Schneeweiss, Andreas, Barrios, Carlos H, Iwata, Hiroji, Diéras, Véronique, Hegg, Roberto, Im, Seock-Ah, Shaw Wright, Gail, Henschel, Volkmar, Molinero, Luciana, Chui, Stephen Y, Funke, Roel, Husain, Amreen, Winer, Eric P, Loi, Sherene, Emens, Leisha A

Volltext

Higher Hydroclimatic Intensity with Global Warming von Giorgi, F., Im, E.-S., Coppola, E., Diffenbaugh, N. S., Gao, X. J., Mariotti, L., Shi, Y.

Volltext

Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer von Im, Seock-Ah, Lu, Yen-Shen, Bardia, Aditya, Harbeck, Nadia, Colleoni, Marco, Franke, Fabio, Chow, Louis, Sohn, Joohyuk, Lee, Keun-Seok, Campos-Gomez, Saul, Villanueva-Vazquez, Rafael, Jung, Kyung-Hae, Chakravartty, Arunava, Hughes, Gareth, Gounaris, Ioannis, Rodriguez-Lorenc, Karen, Taran, Tetiana, Hurvitz, Sara, Tripathy, Debu

Volltext

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer von Turner, Nicholas C, Slamon, Dennis J, Ro, Jungsil, Bondarenko, Igor, Im, Seock-Ah, Masuda, Norikazu, Colleoni, Marco, DeMichele, Angela, Loi, Sherene, Verma, Sunil, Iwata, Hiroji, Harbeck, Nadia, Loibl, Sibylle, André, Fabrice, Puyana Theall, Kathy, Huang, Xin, Giorgetti, Carla, Huang Bartlett, Cynthia, Cristofanilli, Massimo

Volltext

Size Correlation of Optical and Spectroscopic Properties for Gold Nanoparticles von Njoki, Peter N, Lim, I-Im S, Mott, Derrick, Park, Hye-Young, Khan, Bilal, Mishra, Suprav, Sujakumar, Ravishanker, Luo, Jin, Zhong, Chuan-Jian

Volltext

Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer von Cortés, J., Baselga, J., Im, Y.-H., Im, S.-A., Pivot, X., Ross, G., Clark, E., Knott, A., Swain, S.M.

Volltext

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS von Park, Y.H., Senkus-Konefka, E., Im, S.-A., Pentheroudakis, G., Saji, S., Gupta, S., Iwata, H., Mastura, M.Y., Dent, R., Lu, Y.-S., Yin, Y., Smruti, B.K., Toyama, T., Malwinder, S., Lee, S.C., Tseng, L.-M., Kim, J.H., Kim, T.-Y., Suh, K.J., Cardoso, F., Yoshino, T., Douillard, J.-Y.

Volltext

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatme... von Pivot, X., Bondarenko, I., Nowecki, Z., Dvorkin, M., Trishkina, E., Ahn, J.-H., Im, S.-A., Sarosiek, T., Chatterjee, S., Wojtukiewicz, M.Z., Shparyk, Y., Moiseyenko, V., Bello, M., Semiglazov, V., Lee, Y., Lim, J.

Volltext

Forward osmosis (FO)-reverse osmosis (RO) hybrid process incorporated with hollow fiber FO von Im, S.-J., Jeong, S., Jang, A.

Volltext

Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer von Kim, H-P, Han, S-W, Song, S-H, Jeong, E-G, Lee, M-Y, Hwang, D, Im, S-A, Bang, Y-J, Kim, T-Y

Volltext

Aspiration and dysphagia screening in acute stroke – the Gugging Swallowing Screen revisited von Warnecke, T., Im, S., Kaiser, C., Hamacher, C., Oelenberg, S., Dziewas, R.

Volltext